Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 111Lung Neoplasms 54Adenocarcinoma of Lung 10Breast Neoplasms 9Small Cell Lung Carcinoma 5Neoplasms 5Mesothelioma, Malignant 5NSCLC 4Mesothelioma 3Adenocarcinoma, Bronchiolo-Alveolar 3Thoracic Neoplasms 2Recurrence 2Prostatic Neoplasms 2Ovarian Neoplasms 2Non-small Cell Lung Cancer Metastatic 2Lung Diseases 2Carcinoma, Ovarian Epithelial 2Advanced Non-Small Cell Lung Cancer 2Adenocarcinoma 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Solitary Fibrous Tumor, Pleural 1Sarcoma 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Pleural Effusion, Malignant 1Pheochromocytoma 1Paraganglioma, Extra-Adrenal 1Pancreatic Neoplasms 1Non-small Cell Lung Cancer Stage â…¡ 1

Interventions

pembrolizumab 2toripalimab 1sintilimab 1pemigatinib 1osimertinib 1durvalumab 1Vinorelbine 1Platinum Compounds 1Nivolumab 1Ipilimumab 1Drug Therapy 1AZD 6244 11-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Non Small Cell Lung Cancer × Vinorelbine × Thoracic × Clear all
NCT03652857 2020-02-17

Apatinib Combined With Vinorelbine for Non-driver Gene Mutation Non-small Cell Lung Cancer

Hunan Province Tumor Hospital

Phase 2 Completed
30 enrolled
Thoracic

Advanced Non Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡